A feasible strategy for preventing blood clots in critically ill patients with acute kidney injury (FBI): study protocol for a randomized controlled trial

BACKGROUND: Previous pharmacokinetic trials suggested that 40 mg subcutaneous enoxaparin once daily provided inadequate thromboprophylaxis for intensive care unit patients. Critically ill patients with acute kidney injury are at increased risk of venous thromboembolism and yet are often excluded fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Sian, Zincuk, Aleksander, Larsen, Ulla Lei, Ekstrøm, Claus, Toft, Palle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061539/
https://www.ncbi.nlm.nih.gov/pubmed/24925372
http://dx.doi.org/10.1186/1745-6215-15-226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061539/
https://www.ncbi.nlm.nih.gov/pubmed/24925372
http://dx.doi.org/10.1186/1745-6215-15-226

Ejemplares similares